Scroll Back to Top

Advancing Precision Oncology: Leveraging multidimensional biomarker insights with CGIP

While the use of precision therapies continues to expand, precision oncology drug development is facing increasing costs and complexity. In today's biomarker-driven landscape, it is more important than ever to implement strategies and solutions for maximizing efficiencies throughout the drug development process.

Explore the latest innovations in precision oncology services and learn more about comprehensive genomic profiling (CGP) and why it is essential for extracting maximum insights from valuable samples.

Molecular Tumor Board: 59-year-old woman with ESR1 mutant hormone receptor-positive breast cancer

In this Molecular Tumor Board, our Medical Affairs team discussed a case of metastatic hormone receptor (HR)-positive breast cancer where limited tissue precluded tissue-based molecular profiling. A plasma-based ctDNA assay identified an ESR1 mutation associated with endocrine resistance, highlighting the value of liquid biopsy in guiding treatment decisions. This case reinforces the role of liquid biopsy in precision oncology and the importance of assessing ESR1 status in management of HR-positive breast cancer.

<span>On-Demand Webinar: Systemic Mastocytosis - Insights Into A Rare Blood Disorder</span>
March 25, 2025

On-Demand Webinar: Systemic Mastocytosis - Insights Into A Rare Blood Disorder

Presented by guest speaker Dr. Alejandro Gru, MD, Professor of Dermatology and Director of Dermapathology at Columbia University’s Irving Medical Center, this webinar provides information about systemic mastocytosis, a rare blood disorder where abnormal mast cells (white blood cells) build up in different parts of the human body, resulting in a variety of symptoms. It is estimated that over 32,000 United States citizens could be living with this disease, and this webinar profiles what causes systemic mastocytosis, how this condition affects patients, how systemic mastocytosis can be detected and how are patients being treated for this disease.